Novel screening assay to identify and evaluate drugs that target Familial and Sporadic Amyotrophic Lateral Scelrosis
- 詳細技術說明
- In vitro cell-based assay thatenables investigating molecular disease mechanisms and evaluating potentialtherapies for Sporadic Amyotrophic Lateral Sclerosis (ALS).
- *Abstract
-
This is an in vitro cell-based assay that enables investigating molecular disease mechanisms and evaluating potential therapies for Sporadic Amyotrophic Lateral Sclerosis (ALS). This assay utilizes human derived cells from individuals with the disease.
- *Inquiry
- Margaret Barkett, Ph.D.The Research Institute atNationwide Children's HospitalOffice of TechnologyCommercialization700 Children's DriveColumbus OH 43205T: 614 355-2957 F: 614722-2716Margaret.Barkett@nationwidechildrens.org
- *IP Issue Date
- None
- *IP Type
- Other Patent
- 國家
- Not Available
- 申請號碼
- None
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
